RadNet's Revenue Climbs 10% Amidst Widening Net Loss

Ticker: RDNT · Form: 10-Q · Filed: Nov 10, 2025 · CIK: 790526

Radnet, Inc. 10-Q Filing Summary
FieldDetail
CompanyRadnet, Inc. (RDNT)
Form Type10-Q
Filed DateNov 10, 2025
Risk Levelmedium
Pages16
Reading Time19 min
Key Dollar Amounts$0.0001
Sentimentmixed

Sentiment: mixed

Topics: Diagnostic Imaging, Healthcare Services, Acquisitions, Net Loss, Revenue Growth, Operating Expenses, Cash Flow

Related Tickers: RDNT

TL;DR

**RadNet's revenue growth is overshadowed by a ballooning net loss, making it a risky bet despite operational cash flow.**

AI Summary

RadNet, Inc. (RDNT) reported a mixed financial performance for the nine months ended September 30, 2025. Total service revenue increased to $1,492,498,000 from $1,352,563,000 in the prior year, a 10.3% increase. However, net income attributable to RadNet, Inc. common stockholders saw a significant loss of $18,055,000, compared to a loss of $2,552,000 for the same period in 2024. This expanded loss was primarily driven by increased operating expenses, including a substantial rise in cost of operations to $1,332,944,000 from $1,169,113,000, and new lease abandonment charges of $8,330,000. The company also incurred higher depreciation and amortization expenses of $111,275,000, up from $101,822,000. Strategic acquisitions continued, with the purchase of iCAD, Inc. for $105,800,000 in common stock on July 17, 2025, and other imaging facilities totaling $66,464,000. Cash and cash equivalents increased to $804,716,000 at September 30, 2025, from $740,020,000 at December 31, 2024, reflecting strong cash provided by operating activities of $214,656,000.

Why It Matters

RadNet's continued revenue growth, driven by service fee increases and strategic acquisitions like iCAD, Inc., signals strong market demand for diagnostic imaging. However, the widening net loss for common stockholders, despite operational cash flow improvements, raises questions about profitability and cost management. Investors should scrutinize the impact of rising operating expenses and lease abandonment charges on future earnings. For employees, the expansion through acquisitions could mean new opportunities, while customers might see an expanded network of services. In a competitive healthcare landscape, RadNet's ability to integrate acquisitions efficiently and control costs will be crucial for long-term market positioning.

Risk Assessment

Risk Level: medium — The company reported a net loss attributable to common stockholders of $18,055,000 for the nine months ended September 30, 2025, a significant increase from the $2,552,000 loss in the prior year. This widening loss, coupled with new lease abandonment charges of $8,330,000 and a substantial increase in cost of operations, indicates potential challenges in maintaining profitability despite revenue growth.

Analyst Insight

Investors should closely monitor RadNet's upcoming earnings calls for detailed explanations on cost control strategies and the integration progress of recent acquisitions. While revenue growth is positive, the increasing net loss suggests that the company's expansion efforts are not yet translating into improved shareholder value. Consider holding or reducing exposure until a clear path to profitability is demonstrated.

Financial Highlights

debt To Equity
1.79
revenue
$1,492,498,000
operating Margin
2.1%
total Assets
$3,665,279,000
total Debt
$1,096,340,000
net Income
-$18,055,000
eps
Not Disclosed
gross Margin
Not Disclosed
cash Position
$804,716,000
revenue Growth
+10.3%

Revenue Breakdown

SegmentRevenueGrowth
Service fee revenue$1,398,838,000+12.1%
Revenue under capitation arrangements$93,660,000-10.8%

Key Numbers

  • $1,492,498,000 — Total service revenue (Increased from $1,352,563,000 in 2024, a 10.3% increase for the nine months ended September 30, 2025.)
  • $18,055,000 — Net loss attributable to RadNet, Inc. common stockholders (Widened from a $2,552,000 loss in 2024 for the nine months ended September 30, 2025.)
  • $8,330,000 — Lease abandonment charges (New expense incurred for the nine months ended September 30, 2025, not present in 2024.)
  • $1,332,944,000 — Cost of operations (Increased from $1,169,113,000 in 2024 for the nine months ended September 30, 2025.)
  • $105,800,000 — Value of common stock issued for iCAD, Inc. acquisition (Issued on July 17, 2025, as part of a strategic acquisition.)
  • $804,716,000 — Cash and cash equivalents (Increased from $740,020,000 at December 31, 2024, as of September 30, 2025.)
  • $214,656,000 — Net cash provided by operating activities (Increased from $190,494,000 in 2024 for the nine months ended September 30, 2025.)
  • 407 — Number of centers operated (As of September 30, 2025, across eight states.)

Key Players & Entities

  • RadNet, Inc. (company) — national provider of freestanding, fixed-site outpatient diagnostic imaging services
  • iCAD, Inc. (company) — company acquired by RadNet for $105.8 million
  • Dignity Health (company) — related party and joint venture member of Arizona Diagnostic Radiology Group, LLC
  • Arizona Diagnostic Radiology Group, LLC (company) — joint venture with Dignity Health
  • Heart & Lung Imaging Limited (company) — company acquired by RadNet
  • Ventura County Imaging Group, LLC (company) — majority owned subsidiary where economic interest was sold
  • Tri Valley Imaging Group, LLC (company) — joint venture where RadNet received fixed assets and goodwill
  • NASDAQ Global Market (regulator) — exchange where RDNT common stock is traded

FAQ

What were RadNet's total service revenues for the nine months ended September 30, 2025?

RadNet's total service revenues for the nine months ended September 30, 2025, were $1,492,498,000, an increase from $1,352,563,000 for the same period in 2024.

What was the net income (loss) attributable to RadNet, Inc. common stockholders for the nine months ended September 30, 2025?

For the nine months ended September 30, 2025, RadNet reported a net loss attributable to common stockholders of $18,055,000, which is a significant increase from the $2,552,000 loss reported in the prior year.

How much did RadNet spend on the acquisition of iCAD, Inc.?

On July 17, 2025, RadNet issued 1,848,152 shares of common stock, ascribed a value of $105,800,000, to complete its purchase of iCAD, Inc.

What were RadNet's cash and cash equivalents at September 30, 2025?

As of September 30, 2025, RadNet's cash and cash equivalents stood at $804,716,000, up from $740,020,000 at December 31, 2024.

What was the impact of lease abandonment charges on RadNet's operating expenses?

RadNet incurred $8,330,000 in lease abandonment charges for the nine months ended September 30, 2025, which contributed to the overall increase in operating expenses compared to no such charges in the prior year.

How many diagnostic imaging centers does RadNet operate?

At September 30, 2025, RadNet operated directly or indirectly through joint ventures with hospitals, 407 centers located across Arizona, California, Delaware, Florida, Maryland, New Jersey, New York, and Texas.

What is the primary business of RadNet, Inc.?

RadNet, Inc. is a national provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States, offering services such as MRI, CT, PET, nuclear medicine, mammography, ultrasound, and X-ray.

What was the change in RadNet's goodwill for the nine months ended September 30, 2025?

RadNet's goodwill increased to $827,532,000 at September 30, 2025, from $710,663,000 at December 31, 2024, reflecting recent acquisitions.

How did RadNet's net cash provided by operating activities change year-over-year?

Net cash provided by operating activities increased to $214,656,000 for the nine months ended September 30, 2025, from $190,494,000 for the same period in 2024.

What is the significance of RadNet's consolidation of Variable Interest Entities (VIEs)?

RadNet consolidates VIEs, such as the Consolidated Medical Group, where it is the primary beneficiary, meaning it has the power to direct activities and absorb losses or receive benefits. This allows RadNet to include the revenue, expenses, assets, and liabilities of these professional medical service providers in its consolidated financial statements.

Risk Factors

  • Integration of Acquired Businesses [medium — operational]: The company has a history of strategic acquisitions, including iCAD, Inc. for $105,800,000 in common stock and other imaging facilities for $66,464,000. Failure to successfully integrate these acquired businesses could disrupt operations, impact financial performance, and dilute shareholder value.
  • Changes in Healthcare Reimbursement and Regulations [high — regulatory]: RadNet operates in a highly regulated healthcare industry. Changes in government reimbursement policies, such as Medicare and Medicaid, or new healthcare regulations could adversely affect revenue and profitability. The company's revenue from capitation arrangements decreased by 10.8% for the nine months ended September 30, 2025.
  • Increased Operating Expenses and Net Loss [high — financial]: For the nine months ended September 30, 2025, cost of operations increased by 14.0% to $1,332,944,000, and the company incurred new lease abandonment charges of $8,330,000. This led to a widened net loss attributable to common stockholders of $18,055,000, compared to a loss of $2,552,000 in the prior year.
  • Dependence on Key Personnel and Technology [medium — operational]: The company relies on skilled medical professionals and advanced technology for its diagnostic imaging services. Any disruption in the availability of key personnel or the failure of critical technology could impact service delivery and patient care.
  • Competition in the Diagnostic Imaging Market [medium — market]: The diagnostic imaging market is competitive, with numerous national and local providers. RadNet faces competition from hospitals, independent imaging centers, and physician groups, which could pressure pricing and market share.

Industry Context

The diagnostic imaging industry is characterized by technological advancements, increasing demand for outpatient services, and a complex regulatory environment. RadNet operates within this landscape, competing with both large national players and smaller regional providers. Trends include the shift towards value-based care and the integration of artificial intelligence in image analysis.

Regulatory Implications

RadNet is subject to extensive healthcare regulations, including those governing Medicare and Medicaid reimbursement. Changes in these reimbursement rates or new compliance requirements can significantly impact financial performance. The company's revenue mix, including capitation arrangements, is also sensitive to regulatory shifts.

What Investors Should Do

  1. Monitor operating expense trends, particularly cost of operations and lease-related charges.
  2. Analyze the integration success of recent acquisitions, such as iCAD, Inc.
  3. Evaluate the sustainability of cash flow generation in light of increased operating costs.
  4. Assess the impact of declining capitation revenue on the overall business model.

Key Dates

  • 2025-07-17: Acquisition of iCAD, Inc. — Represents a strategic expansion through the issuance of $105,800,000 in common stock, indicating growth initiatives.
  • 2025-09-30: End of Nine Months Reporting Period — Period during which total service revenue grew 10.3% to $1,492,498,000, but net loss widened to $18,055,000.
  • 2025-09-30: Consolidated Balance Sheet Date — Showcased cash and cash equivalents of $804,716,000, an increase from year-end 2024, supported by strong operating cash flow.

Glossary

Revenue under capitation arrangements
Revenue recognized when a healthcare provider agrees to provide a defined set of services to a patient for a fixed amount of money, regardless of the actual services rendered. (This revenue stream decreased by 10.8% for the nine months ended September 30, 2025, impacting overall revenue mix.)
Lease abandonment charges
Costs incurred when a company decides to cease using a leased property before the lease term expires, often including costs to terminate the lease or costs associated with vacating the premises. (A new expense of $8,330,000 for the nine months ended September 30, 2025, contributing to the increased operating expenses and net loss.)
Right-of-use assets
Assets recognized under accounting standards (ASC 842) that represent a lessee's right to use an identified asset for a period of time. (These assets, related to operating leases, increased to $675,330,000 as of September 30, 2025, reflecting the company's leasing activities.)
Goodwill
An intangible asset that arises when a company acquires another company for a price greater than the fair value of its identifiable net assets. (Goodwill increased significantly to $827,532,000 as of September 30, 2025, primarily due to acquisitions.)
Noncontrolling interests
The portion of equity of a subsidiary that is not attributable to the parent company. (Represents ownership interests in subsidiaries that are not owned by RadNet, Inc. common stockholders, amounting to $255,419,000 as of September 30, 2025.)

Year-Over-Year Comparison

For the nine months ended September 30, 2025, RadNet reported a 10.3% increase in total service revenue to $1,492,498,000, up from $1,352,563,000 in the prior year. However, this revenue growth was overshadowed by a significant increase in operating expenses, including a 14.0% rise in the cost of operations and new lease abandonment charges, leading to a widened net loss of $18,055,000 compared to $2,552,000 in the prior year. Total assets grew to $3,665,279,000 from $3,286,690,000, driven by acquisitions and increased property, equipment, and goodwill.

Filing Stats: 4,703 words · 19 min read · ~16 pages · Grade level 16.2 · Accepted 2025-11-10 16:07:44

Key Financial Figures

  • $0.0001 — mbol Registered Exchange Common Stock, $0.0001 par value RDNT NASDAQ Global Market I

Filing Documents

– FINANCIAL INFORMATION

PART I – FINANCIAL INFORMATION 1

Financial Statements

ITEM 1. Financial Statements 1 Condensed Consolidated Balance Sheets at September 3 0 , 202 5 and December 31, 20 24 1 Condensed Consolidated Statements of Operations for the Three and Nine Months Ended Sept ember 30 , 202 5 and 20 24 2 Condensed Consolidated Statements of Comprehensive i ncome (loss) for the Three and Nine Months Ended September 30 , 202 5 and 20 24 3 Condensed Consolidated Statement of Stockholders' Equity for the Three and N ine Months Ended September 3 0 , 202 5 and 202 4 4 Condensed Consolidated Statements of Cash Flows for the Nine Months Ended September 30 , 202 5 and 202 4 7 Notes to Condensed Consolidated Financial Statements 9

Management's Discussion and Analysis of Financial Condition and Results of Operations

ITEM 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 32

Quantitative and Qualitative Disclosures About Market Risk

ITEM 3. Quantitative and Qualitative Disclosures About Market Risk 50

Controls and Procedures

ITEM 4. Controls and Procedures 51

– OTHER INFORMATION

PART II – OTHER INFORMATION 52

Legal Proceedings

ITEM 1. Legal Proceedings 52

Risk Factors

ITEM 1A. Risk Factors 52

Unregistered Sales of Equity Securities and Use of Proceeds

ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds 52

Defaults Upon Senior Securities

ITEM 3. Defaults Upon Senior Securities 52

Mine Safety Disclosures

ITEM 4. Mine Safety Disclosures 52

Other Information

ITEM 5. Other Information 52

Exhibits

ITEM 6. Exhibits 52

SIGNATURES

SIGNATURES 53 i Table of Contents

- FINANCIAL INFORMATION

PART I - FINANCIAL INFORMATION

– Financial Statements

Item 1 – Financial Statements RADNET, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS (IN THOUSANDS EXCEPT SHARE DATA) September 30, 2025 December 31, 2024 (unaudited) ASSETS CURRENT ASSETS Cash and cash equivalents $ 804,716 $ 740,020 Accounts receivable 210,548 185,821 Due from affiliates 12,362 41,869 Prepaid expenses and other current assets 50,151 51,542 Total current assets 1,077,777 1,019,252 PROPERTY, EQUIPMENT AND RIGHT-OF-USE ASSETS Property and equipment, net 780,502 694,791 Operating lease right-of-use assets 675,330 639,740 Total property, equipment and right-of-use assets 1,455,832 1,334,531 OTHER ASSETS Goodwill 827,532 710,663 Other intangible assets 124,912 81,351 Deferred financing costs 1,829 2,265 Investment in joint ventures 129,127 104,057 Deferred tax assets, net 5,261 — Deposits and other 43,009 34,571 Total assets $ 3,665,279 $ 3,286,690 LIABILITIES AND EQUITY CURRENT LIABILITIES Accounts payable, accrued expenses and other $ 419,207 $ 351,464 Due to affiliates 61,748 43,650 Deferred revenue 8,170 3,288 Current operating lease liability 60,335 56,618 Current portion of notes payable 25,454 24,692 Total current liabilities 574,914 479,712 LONG-TERM LIABILITIES Long-term operating lease liability 690,935 655,979 Notes payable, net of current portion 1,070,886 991,574 Deferred tax liability, net — 22,230 Other non-current liabilities 14,585 3,785 Total liabilities 2,351,320 2,153,280 EQUITY Common stock - $ 0.0001 par value, 200,000,000 shares authorized; 77,032,154 and 74,036,993 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively 8 7 Additional paid-in-capital 1,147,402 988,147 Accumulated other comprehensive income (loss) 5,970 ( 9,061 ) Accumulated deficit ( 94,840 ) ( 76,785 ) Total RadNet, Inc.'s Stockholders' equity: 1,058,540 902,308 Noncontrolling interests 255,419 231,102 Total equity 1,313,959 1,133,410 Total liabilities and equity $

View Full Filing

View this 10-Q filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.